MDS Clinical Supportive Criteria for Parkinson’s Disease are Associated with α-Synuclein Seed Amplification Assay Status
Objective: To assess the association between α-synuclein seed amplification assay (α-synuclein SAA) status with the supportive criteria of the MDS Clinical Diagnostic Criteria for Parkinson’s…Association Between DPP-4 Inhibitors Use and Risk of Dementia: A Meta-analysis Using Real-world Data
Objective: To investigate the potential association between the use of DPP-4 inhibitors and the risk of dementia, utilizing real-world data from diverse sources. Background: Evidence…Quantitative Assessment of X-linked Dystonia-Parkinsonism Using Wearable Sensing Technology
Objective: To create a quantitative, objective framework for assessing combined dystonia parkinsonism using kinematic data from wearable sensors combined with machine learning (ML), enabling clinician-independent…The Impact of Camp Lejeune Toxins on the Development of Parkinsonisms and Movement Disorders
Objective: To further characterize movement disorders seen in Veterans exposed to toxins at Camp Lejeune military base. Background: Recent reports reveal that water in the…Comparison of Composite Method Calculations for Monitoring Disease Progression in Early Parkinson’s Disease
Objective: Objective: To evaluate the influence of composite scoring methodologies using digital measures of gait, tremor, and bradykinesia to monitor disease progression over one year…Parkinsonism due to Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP) Responsive to Carbidopa/Levodopa
Objective: To describe a case of Parkinsonism due to ALSP which is responsive to carbidopa/levodopa Background: Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP)…The impact of cognitive impairment and Alzheimer’s disease neuropathological changes on gait and falls in Parkinson’s disease
Objective: To investigate the association between clinical markers of cognitive impairment, severity, and distribution of Alzheimer's disease neuropathological changes (ADNC) with gait difficulties, freezing of…Creation and Performance of a Cognitive Summary Score in de novo Parkinson’s Disease: Results from the PPMI Study
Objective: To determine if a cognitive summary score (CSS) is sensitive in detecting early cognitive deficits in de novo Parkinson’s disease (PD). Background: Cognitive impairment…Characterisation and longitudinal significance of subjective cognitive decline in GBA and LRRK2 Parkinson’s disease
Objective: To investigate the clinical characteristics and predictive value associated with subjective cognitive decline (SCD) in people with Parkinson’s disease (PD) carrying pathogenic GBA or…Semantic Memory in Parkinson’s Disease: Linguistic Features and Neural Correlates
Objective: This study aims to characterize behavioral and neural correlates of semantic processing in Parkinson’s disease (PD). Background: Cognitive studies on PD reveal abnormalities during…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.